Target intelligence / Profile preview

Inhibin beta A chain (INHBA)

Target
INHBA
Molecular classification
Other
01

Overview

Inhibin beta A chain (encoded by the INHBA gene) is a subunit that can homodimerize to form activin A, or heterodimerize with an alpha subunit to form inhibin A, or with a beta B subunit to form activin AB. Activin A is a secreted cytokine belonging to the transforming growth factor-beta (TGF-beta) superfamily. It plays critical roles in embryonic development, cell proliferation, apoptosis, immune response, and tissue homeostasis. Pathologically, overexpressed activin A is implicated in cancer progression, metastasis, cachexia, and pulmonary arterial hypertension (PAH). In fibrodysplasia ossificans progressiva (FOP), activin A aberrantly activates mutant ACVR1 receptors, driving progressive heterotopic ossification. Therapeutic strategies targeting this molecule include monoclonal antibodies like garetosmab, which specifically neutralize activin A, and soluble receptor-Fc fusion proteins (ligand traps) like sotatercept and STM-434, which sequester activin A and other TGF-beta ligands to restore signaling balance.

Other names
Inhibin subunit beta AActivin beta-A chainErythroid differentiation proteinEDFFSH-releasing proteinFollicle-stimulating hormone-releasing proteinActivin A
02

Mechanism of action

Inhibition of activin A signaling by binding and neutralizing the ligand (either via a monoclonal antibody or a soluble receptor-Fc ligand trap), thereby preventing its interaction with type I and type II activin receptors and restoring the balance of downstream SMAD signaling pathways.

03

Biological functions

Signal transductionCell cycleApoptosisImmune responseCell proliferationCell deathOther
04

Disease associations

CancerInflammationCardiovascular diseaseOther
05

Safety considerations

Epistaxis (nosebleeds)TelangiectasiaIncreased hemoglobin/hematocrit (polycythemia)ThrombocytopeniaFatigueGingival bleedingSkin and soft tissue infectionsMadarosis
06

Interacting drugs

2 more in the full profile.

07

Biomarkers

Activin A levelsFollicle-stimulating hormone (FSH) levelsN-terminal pro-B-type natriuretic peptide (NT-proBNP)Pulmonary vascular resistance (PVR)Hemoglobin levels

Beyond the preview

Go deeper on Inhibin beta A chain (INHBA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inhibin beta A chain (INHBA).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call